"Centre de referència per a les comarques del Baix Camp, el Priorat i la Ribera d’Ebre i part de la Terra Alta, en Oncologia, Cirurgia Bariàtrica, Cirurgia Plàstica i Reparadora, Nutrició o Cirurgia Toràcica."

During the past decade, Hospital Universitari Sant Joan de Reus conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 19 clinical trials were completed, i.e. on average, 34.5% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 15 clinical trials were completed. i.e. 53.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitari Sant Joan de Reus" #1 sponsor was "SOLTI Breast Cancer Research Group" with 10 trials, followed by "Spanish Breast Cancer Research Group" with 9 trials sponsored, "Pfizer" with 7 trials sponsored, "MedSIR" with 5 trials sponsored and "ETOP IBCSG Partners Foundation" with 5 trials sponsored. Other sponsors include 53 different institutions and companies that sponsored additional 46 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitari Sant Joan de Reus" #1 collaborator was "Pfizer" with 6 trials as a collaborator, "Breast International Group" with 5 trials as a collaborator, "Hospital Universitari Sant Joan de Reus" with 5 trials as a collaborator, "AstraZeneca" with 4 trials as a collaborator and "ETOP IBCSG Partners Foundation" with 3 trials as a collaborator. Other collaborators include 79 different institutions and companies that were collaborators in the rest 72 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitari Sant Joan de Reus" are "Breast Cancer" (19 trials), "Advanced Breast Cancer" (5 trials), "Metastatic Breast Cancer" (5 trials), "Breast Neoplasms" (3 trials) and "HIV Infections" (3 trials). Many other conditions were trialed in "Hospital Universitari Sant Joan de Reus" in a lesser frequency.

Most popular intervention types in "Hospital Universitari Sant Joan de Reus" are "Drug" (68 trials), "Other" (7 trials), "Dietary Supplement" (5 trials), "Biological" (4 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Fulvestrant" (5 trials), "Palbociclib" (5 trials), "Trastuzumab" (4 trials) and "Capecitabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitari Sant Joan de Reus" are 66 trials for "All" genders, 25 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitari Sant Joan de Reus". undefined are not yet recruiting, 22 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 47 completed trials in Hospital Universitari Sant Joan de Reus, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitari Sant Joan de Reus, 2 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 10 trials that are defined as “Not Applicable".

Hospital Universitari Sant Joan de Reus has several departments that took part in Clinical trials: "Hospital Universitari Sant Joan de Reus; Servicio de Oncologia" - 6 trials